Andre Koltermann
17Patents
6h-index
41Co-inventors
62Inventor score
Filing activity: Jun 11, 1998 → Sep 2, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7335504B2 | Engineered enzymes and uses thereof | Chemistry; Metallurgy | 81 | Expired |
| US8143045B2 | Mutant Citrobacter freundii phytase polypeptide | Chemistry; Metallurgy | 68 | Active |
| US7170598B2 | Multi-parameter fluorimetric analysis in a massively parallel multi-focal arrangement and the use thereof | Physics | 24 | Expired |
| US6200818A | Method for detecting reactions by means of coincidence analysis | Physics | 15 | Expired |
| US8859247B2 | Process for cell-free production of chemicals | Emerging Cross-Sectional Technologies | 14 | Active |
| US6821758B1 | Method for the production of biopolymers with modified properties | Chemistry; Metallurgy | 11 | Expired |
| US7507582B2 | Method and device for multicolour 2-photon fluorescence coincidence analysis | Emerging Cross-Sectional Technologies | 6 | Expired |
| US8470963B2 | Multifunctional compounds for pharmaceutical purposes | Chemistry; Metallurgy | 4 | Active |
| US8053221B2 | Enzymes | Chemistry; Metallurgy | 4 | Active |
| US8524471B2 | Generation of chemical building blocks from plant biomass by selective depolymerization | Chemistry; Metallurgy | 4 | Active |
| US6114510A | Process for the purification of recombinant human interleukin-8 | Chemistry; Metallurgy | 3 | Expired |
| US9005936B2 | Liquefied biomass | Emerging Cross-Sectional Technologies | 1 | Active |
| US9273295B2 | Mutant citrobacter freundii phytase polypeptide | Chemistry; Metallurgy | 0 | Active |
| US8679795B2 | Thermostable xylanase for the selective hydrolysis of pentose-containing polysaccharides | Emerging Cross-Sectional Technologies | 0 | Active |
| US9458443B2 | Optimized cellulase enzymes | Emerging Cross-Sectional Technologies | 0 | Active |
| US9637434B2 | Method for obtaining ethanol during fermentation | Emerging Cross-Sectional Technologies | 0 | Active |
| US10202421B2 | Tumor-targeting compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.